Endogenous synthesis of n-3 PUFA modifies fatty acid composition of kidney phospholipids and eicosanoid levels in the fat-1 mouse

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 89, Issue 4, 2013, Pages 169-177

  Kelton, D ^a   Lysecki, C ^b   Aukema, H ^b   Anderson, B ^a   Kang, J X ^c   Ma, D W L ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Arachidonic acid; Docosahexaenoic acid; Eicosanoids; Eicosapentaenoic acid; Fat 1; Kidney; Phospholipid; Polyunsaturated fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSANOID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PHOSPHOLIPID;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FATTY ACID SYNTHESIS; FEMALE; FOOD COMPOSITION; FOOD INTAKE; GAS CHROMATOGRAPHY; GENOTYPE; KIDNEY; KIDNEY DISEASE; LIPID COMPOSITION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; TRANSGENE;

MUS;

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; EICOSANOIDS; EICOSAPENTAENOIC ACID; FAT-1; KIDNEY; PHOSPHOLIPID; POLYUNSATURATED FATTY ACIDS;

ANIMALS; CADHERINS; DIET; EICOSANOIDS; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; KIDNEY; MALE; MICE; MICE, TRANSGENIC; PHOSPHOLIPIDS;

EID: 84884533448     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2013.08.002     Document Type: Article

References (58)

1. Cornell L.D., Smith R.N., Colvin R.B. Kidney transplantation: mechanisms of rejection and acceptance. Annu. Rev. Pathol. 2008, 3:189-220.
2. Mackensen-Haen S. Correlations between renal cortical interstitial fibrosis, atrophy of the proximal tubules and impairment of the glomerular filtration rate. Clin. Nephrol. 1981, 15:167-171.
3. Roberts M.F. Phospholipases: structural and functional motifs for working at an interface. FASEB J. 1996, 10:1159-1172.
4. Sapirstein A., Bonventre J.V. Specific physiological roles of cytosolic phospholipase A(2) as defined by gene knockouts. Biochim. Biophys. Acta 2000, 1488:139-148.
5. Gijon M.A., Leslie C.C. Regulation of arachidonic acid release and cytosolic phospholipase A2 activation. J. Leukocyte Biol. 1999, 65:330-336.
6. Serhan C.N., Haeggstrom J.Z., Leslie C.C. Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB J. 1996, 10:1147-1158.
7. Smith W.L., Langenbach R. Why there are two cyclooxygenase isozymes. J. Clin. Invest. 2001, 107:1491-1495.
8. Martin-Venegas R., Casillas R., Jauregui O., Moreno J.J. Rapid simultaneous analysis of cyclooxygenase, lipoxygenase and cytochrome P-450 metabolites of arachidonic and linoleic acids using high performance liquid chromatography/mass spectrometry in tandem mode. J. Pharm. Biomed. Anal. 2011, 56:976-982.
9. Donadio J.V. Omega-3 polyunsaturated fatty acids: a potential new treatment of immune renal disease. Mayo Clin. Proc. 1991, 66:1018-1028.
10. Hamazaki T., Tateno S., Shishido H. Eicosapentaenoic acid and IgA nephropathy. Lancet 1984, 1:1017-1018.
11. Donadio J.V., Larson T.S., Bergstralh E.J., Grande J.P. A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy. J. Am. Soc. Nephrol. 2001, 12:791-799.
12. Shi Y., Pestka J.J. Attenuation of mycotoxin-induced IgA nephropathy by eicosapentaenoic acid in the mouse: dose response and relation to IL-6 expression. J. Nutr. Biochem. 2006, 17:697-706.
13. Donadio J.V., Grande J.P., Bergstralh E.J., Dart R.A., Larson T.S., Spencer D.C. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group. J. Am. Soc. Nephrol. 1999, 10:1772-1777.
14. Donadio J.V., Bergstralh E.J., Offord K.P., Spencer D.C., Holley K.E. A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group. N. Engl. J. Med. 1994, 331:1194-1199.
15. Hassan I.R., Gronert K. Acute changes in dietary omega-3 and omega-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1. J. Immunol. 2009, 182:3223-3232.
16. Garman J.H., Mulroney S., Manigrasso M., Flynn E., Maric C. Omega-3 fatty acid rich diet prevents diabetic renal disease,. Am. J. Physiol. Renal. Physiol. 2009, 296:F306-F316.
17. Gopinath B., Harris D.C., Flood V.M., Burlutsky G., Mitchell P. Consumption of long-chain n-3 PUFA, alpha-linolenic acid and fish is associated with the prevalence of chronic kidney disease. Br. J Nutr. 2011, 105:1361-1368.
18. Maaloe T., Schmidt E.B., Svensson M., Aardestrup I.V., Christensen J.H. The effect of n-3 polyunsaturated fatty acids on leukotriene B(4) and leukotriene B(5) production from stimulated neutrophil granulocytes in patients with chronic kidney disease. Prostaglandins Leukot Essent Fatty Acids 2011, 85:37-41.
19. Yasui T., Suzuki S., Itoh Y., Tozawa K., Tokudome S., Kohri K. Eicosapentaenoic acid has a preventive effect on the recurrence of nephrolithiasis. Urol. Int. 2008, 81:135-138.
20. van der Heide J.J., Bilo H.J., Donker J.M., Wilmink J.M., Tegzess A.M. Effect of dietary fish oil on renal function and rejection in cyclosporine-treated recipients of renal transplants. N. Engl. J. Med. 1993, 329:769-773.
21. Kang J.X., Wang J., Wu L., Kang Z.B. Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature 2004, 427:504.
22. MacLennan M.B., Clarke S.E., Perez K., Wood G.A., Muller W.J., Kang J.X., Ma D.W. Mammary tumor development is directly inhibited by lifelong n-3 polyunsaturated fatty acids. J. Nutr. Biochem. 2013, 24:388-395.
23. Lau B.Y., Ward W.E., Kang J.X., Ma D.W. Fat-1 gene modulates the fatty acid composition of femoral and vertebral phospholipids. Appl. Physiol. Nutr. Metab. 2010, 35:447-455.
24. Orr S.K., Tong J.Y., Kang J.X., Ma D.W., Bazinet R.P. The fat-1 mouse has brain docosahexaenoic acid levels achievable through fish oil feeding. Neurochem. Res. 2010, 35:811-819.
25. Suh M., Sauve Y., Merrells K.J., Kang J.X., Ma D.W. Supranormal electroretinogram in fat-1 mice with retinas enriched in docosahexaenoic acid and n-3 very long chain fatty acids (C24-C36). Invest. Ophthalmol. Vis. Sci. 2009, 50:4394-4401.
26. Boudrault C., Bazinet R.P., Kang J.X., Ma D.W. Cyclooxygenase-2 and n-6 PUFA are lower and DHA is higher in the cortex of fat-1 mice. Neurochem. Int. 2010, 56:585-589.
27. FOLCH J., LEES M., STANLEY G.H.SLOANE A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226:497-509.
28. Aukema H.M., Lu J., Borthwick F., Proctor S.D. Dietary fish oil reduces glomerular injury and elevated renal hydroxyeicosatetraenoic acid levels in the JCR:LA-cp rat, a model of the metabolic syndrome. Br. J. Nutr. 2012, 1-9.
29. Deems R., Buczynski M.W., Bowers-Gentry R., Harkewicz R., Dennis E.A. Detection and quantitation of eicosanoids via high performance liquid chromatography-electrospray ionization-mass spectrometry. Methods Enzymol. 2007, 432:59-82.
30. Hall L.M., Murphy R.C. Electrospray mass spectrometric analysis of 5-hydroperoxy and 5-hydroxyeicosatetraenoic acids generated by lipid peroxidation of red blood cell ghost phospholipids. J. Am. Soc. Mass Spectrom. 1998, 9:527-532.
31. Simopoulos A.P. Evolutionary aspects of omega-3 fatty acids in the food supply. Prostaglandins Leukot Essent Fatty Acids 1999, 60:421-429.
32. Simopoulos A.P. Importance of the ratio of omega-6/omega-3 essential fatty acids: evolutionary aspects. World Rev. Nutr. Diet. 2003, 92:1-22.
33. Simopoulos A.P. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med (Maywood.) 2008, 233:674-688.
34. Kang J.X. The importance of omega-6/omega-3 fatty acid ratio in cell function. The gene transfer of omega-3 fatty acid desaturase. World Rev. Nutr. Diet. 2003, 92:23-36.
35. Eaton S.B., Eaton S.B., Sinclair A.J., Cordain L., Mann N.J. Dietary intake of long-chain polyunsaturated fatty acids during the paleolithic. World Rev. Nutr. Diet. 1998, 83:12-23.
36. Noori N., Dukkipati R., Kovesdy C.P., Sim J.J., Feroze U., Murali S.B., Bross R., Benner D., Kopple J.D., Kalantar-Zadeh K. Dietary omega-3 fatty acid, ratio of omega-6 to omega-3 intake, inflammation, and survival in long-term hemodialysis patients. Am. J. Kidney Dis. 2011, 58:248-256.
37. Kawashima Y., Mizuguchi H., Kozuka H. Modulation by dietary oils and clofibric acid of arachidonic acid content in phosphatidylcholine in liver and kidney of rat: effects on prostaglandin formation in kidney. Biochim. Biophys. Acta 1994, 1210:187-194.
38. Pischon T., Hankinson S.E., Hotamisligil G.S., Rifai N., Willett W.C., Rimm E.B. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003, 108:155-160.
39. De C.R., Endres S., Kristensen S.D., Schmidt E.B. n-3 fatty acids and renal diseases. Am. J. Kidney Dis. 1994, 24:397-415.
40. Nakamura N., Kumasaka R., Osawa H., Yamabe H., Shirato K., Fujita T., Murakami R., Shimada M., Nakamura M., Okumura K., Hamazaki K., Hamazaki T. Effects of eicosapentaenoic acids on oxidative stress and plasma fatty acid composition in patients with lupus nephritis. In Vivo 2005, 19:879-882.
41. Clark W.F., Parbtani A., Naylor C.D., Levinton C.M., Muirhead N., Spanner E., Huff M.W., Philbrick D.J., Holub B.J. Fish oil in lupus nephritis: clinical findings and methodological implications. Kidney Int. 1993, 44:75-86.
42. De C.R., Caprioli R., Giannessi D., Sicari R., Galli C., Lazzerini G., Bernini W., Carr L., Rindi P. n-3 fatty acids reduce proteinuria in patients with chronic glomerular disease. Kidney Int. 1993, 44:843-850.
43. Miller E.R., Juraschek S.P., Appel L.J., Madala M., Anderson C.A., Bleys J., Guallar E. The effect of n-3 long-chain polyunsaturated fatty acid supplementation on urine protein excretion and kidney function: meta-analysis of clinical trials. Am. J. Clin. Nutr. 2009, 89:1937-1945.
44. Priyamvada S., Priyadarshini M., Arivarasu N.A., Farooq N., Khan S., Khan S.A., Khan M.W., Yusufi A.N. Studies on the protective effect of dietary fish oil on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney. Prostaglandins Leukot Essent Fatty Acids 2008, 78:369-381.
45. Zararsiz I., Sonmez M.F., Yilmaz H.R., Tas U., Kus I., Kavakli A., Sarsilmaz M. Effects of omega-3 essential fatty acids against formaldehyde-induced nephropathy in rats. Toxicol. Ind. Health 2006, 22:223-229.
46. Sabry A., El-Husseini A., Sheashaa H., bdel-Shafy E., El-Dahshan K., bdel-Rahim M., bdel-Kaleek E., bo-Zena H. Colchicine vs. omega-3 fatty acids for prevention of chronic cyclosporine nephrotoxicity in Sprague Dawley rats: an experimental animal model, Arch. Med. Res. 2006, 37:933-940.
47. Robinson D.R., Prickett J.D., Makoul G.T., Steinberg A.D., Colvin R.B. Dietary fish oil reduces progression of established renal disease in (NZB x NZW)F1 mice and delays renal disease in BXSB and MRL/1 strains. Arthritis Rheum. 1986, 29:539-546.
48. Prickett J.D., Robinson D.R., Steinberg A.D. Effects of dietary enrichment with eicosapentaenoic acid upon autoimmune nephritis in female NZB X NZW/F1 mice. Arthritis Rheum. 1983, 26:133-139.
49. Prickett J.D., Robinson D.R., Steinberg A.D. Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB x NZW F1 mice. J. Clin. Invest. 1981, 68:556-559.
50. Chandrasekar B., Troyer D.A., Venkatraman J.T., Fernandes G. Dietary omega-3 lipids delay the onset and progression of autoimmune lupus nephritis by inhibiting transforming growth factor beta mRNA and protein expression. J. Autoimmun. 1995, 8:381-393.
51. Halade G.V., Rahman M.M., Bhattacharya A., Barnes J.L., Chandrasekar B., Fernandes G. Docosahexaenoic acid-enriched fish oil attenuates kidney disease and prolongs median and maximal life span of autoimmune lupus-prone mice. J. Immunol. 2010, 184:5280-5286.
52. Brown S.A., Brown C.A., Crowell W.A., Barsanti J.A., Allen T., Cowell C., Finco D.R. Beneficial effects of chronic administration of dietary omega-3 polyunsaturated fatty acids in dogs with renal insufficiency. J. Lab. Clin. Med. 1998, 131:447-455.
53. Lim A.K., Manley K.J., Roberts M.A., Fraenkel M.B. Fish oil for kidney transplant recipients. Cochrane. Database Syst. Rev. 2007, CD005282.
54. Homan van der Heide JJ, Bilo H.J., Donker A.J., Wilmink J.M., Sluiter W.J., Tegzess A.M. The effects of dietary supplementation with fish oil on renal function and the course of early postoperative rejection episodes in cyclosporine-treated renal transplant recipients. Transplantation 1992, 54:257-263.
55. Bennett W.M., Carpenter C.B., Shapiro M.E., Strom T.B., Hefty D., Tillman M., Abrams J., Ryan D., Kelley V.R. Delayed omega-3 fatty acid supplements in renal transplantation. A double-blind, placebo-controlled study. Transplantation 1995, 59:352-356.
56. Kooijmans-Coutinho M.F., Rischen-Vos J., Hermans J., Arndt J.W., van der Woude F.J. Dietary fish oil in renal transplant recipients treated with cyclosporin-A: no beneficial effects shown. J. Am. Soc. Nephrol. 1996, 7:513-518.
57. Tatsioni A., Chung M., Sun Y., Kupelnick B., Lichtenstein A.H., Perrone R., Chew P., Lau J., Bonis P.A. Effects of fish oil supplementation on kidney transplantation: a systematic review and meta-analysis of randomized, controlled trials. J. Am. Soc. Nephrol. 2005, 16:2462-2470.
58. Gluhovschi G., Gluhovschi A., Anastasiu D., Petrica L., Gluhovschi C., Velciov S. Chronic kidney disease and the involvement of estrogen hormones in its pathogenesis and progression. Rom. J. Intern. Med. 2012, 50:135-144.